Your browser doesn't support javascript.
loading
Clinical outcomes based on multigene profiling in metastatic breast cancer patients.
Basho, Reva K; de Melo Gagliato, Debora; Ueno, Naoto T; Wathoo, Chetna; Chen, Huiqin; Shariati, Maryam; Wei, Caimiao; Alvarez, Ricardo H; Moulder, Stacy L; Sahin, Aysegul A; Roy-Chowdhuri, Sinchita; Chavez-MacGregor, Mariana; Litton, Jennifer K; Valero, Vincent; Luthra, Raja; Zeng, Jia; Shaw, Kenna R; Mendelsohn, John; Mills, Gordon B; Tripathy, Debu; Meric-Bernstam, Funda.
Afiliação
  • Basho RK; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • de Melo Gagliato D; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ueno NT; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wathoo C; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shariati M; Investigational Cancer Therapeutics (Phase I Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wei C; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alvarez RH; Pfizer, Inc, New York, NY, USA.
  • Moulder SL; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sahin AA; The Cancer Treatment Centers of America, Chicago, IL, USA.
  • Roy-Chowdhuri S; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chavez-MacGregor M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Litton JK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Valero V; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Luthra R; Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zeng J; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shaw KR; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mendelsohn J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mills GB; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tripathy D; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Meric-Bernstam F; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncotarget ; 7(47): 76362-76373, 2016 Nov 22.
Article em En | MEDLINE | ID: mdl-27806348
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Família Multigênica / Perfilação da Expressão Gênica Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Família Multigênica / Perfilação da Expressão Gênica Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article